AMR Action Fund

Tweet this page
<
2022
>
Registration as it was on 20 Dec 2022
How to read and use this data card.
Download this datacard

Overview

Lobbying Costs

50,000€ - 99,999€

Financial year: Jan 2020 - Dec 2020

Lobbyists (Full time equivalent)

0.45 Fte (3)

Lobbyists with EP accreditation

0

High-level Commission meetings

1

Lobbying Costs over the years

  • Info

    AMR Action Fund

    EU Transparency Register

    859359848269-33 First registered on 02 Dec 2022

    Goals / Remit

    The AMR Action Fund enables breakthroughs in antimicrobials.
    We invest in companies that are developing urgently needed therapeutics for priority pathogens and advocate for market reforms to change how society values these lifesaving drugs. Our aim is to help launch two to four new antimicrobials within the next decade and create a sustainable ecosystem of investment and innovation to take on one of the biggest global health challenges of our generation.

    Main EU files targeted

    Activities related to antimicrobial development, including incentives for innovation and equitable access, most recently the Pharmaceutical Legislation Revision

    Address

    Head Office
    225 Franklin Street Suite 1750
    Boston
    UNITED STATES
    EU Office
    Messeplatz 10
    Basel
    SWITZERLAND

    Website

  • People

    Total lobbyists declared

    3

    Employment timeLobbyists
    25%1
    10%2

    Lobbyists (Full time equivalent)

    0.45

    Lobbyists with EP accreditation

    No lobbyists with EP accreditations

    Complementary Information

    None declared

    Person in charge of EU relations

    Data not provided by Register Secretariat due to GDPR

    Person with legal responsibility

    Data not provided by Register Secretariat due to GDPR

  • Categories

    Category

    Companies & groups

  • Networking

    Affiliation

    The AMR Action Fund is a member of the Swiss Roundtable on Antibiotics: https://roundtableantibiotics.ch/de/about-us

    Member organisations

    None declared

  • Financial Data

    Interests represented

    Promotes their own interests or the collective interests of their members

    Closed financial year

    Jan 2020 - Dec 2020

    Lobbying costs for closed financial year

    50,000€ - 99,999€

    Major contributions in closed year

    None declared

    Intermediaries for closed year

    None declared

    Intermediaries for current year

    None declared

    Closed year Costs

    50,000€ - 99,999€

    Other financial info

    None declared

  • EU Structures

    Groups (European Commission)

    none

    Groups (European Parliament)

    N/A

    Other activities

    None declared

  • Meetings

    Meetings

    1 meetings found. Download meetings

    The list below only covers meetings held since November 2014 with commissioners, their cabinet members or directors-general at the European Commission; other lobby meetings with lower-level staff may have taken place, but the European Commission doesn't publish information about such meetings. All information below comes from European Commission web pages.

    • Date 07 Dec 2022 Location Brussels
      Subject Antimicrobial Resistance
      Cabinet Cabinet of Commissioner Stella Kyriakides
      Portfolio Health
      Attending
      • Annukka Ojala (Cabinet member)
Download this datacard